Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Preservation of nutritional-status in patients with refractory ascites due to hepatic cirrhosis who are undergoing repeated paracentesis.
Sorrentino P, Castaldo G, Tarantino L, Bracigliano A, Perrella A, Perrella O, Fiorentino F, Vecchione R, D' Angelo S.
J Gastroenterol Hepatol. 2012 Apr;27(4):813-22. doi: 10.1111/j.1440-1746.2011.07043.x.
Related citations
Late evening snack: exploiting a period of anabolic opportunity in cirrhosis.
Tsien CD, McCullough AJ, Dasarathy S.
J Gastroenterol Hepatol. 2012 Mar;27(3):430-41. doi: 10.1111/j.1440-1746.2011.06951.x.
Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease.
Adams LA, George J, Bugianesi E, Rossi E, De Boer WB, van der Poorten D, Ching HL, Bulsara M, Jeffrey GP.
J Gastroenterol Hepatol. 2011 Oct;26(10):1536-43. doi: 10.1111/j.1440-1746.2011.06774.x.
Management of ascites in cirrhosis.
Wong F.
J Gastroenterol Hepatol. 2012 Jan;27(1):11-20. doi: 10.1111/j.1440-1746.2011.06925.x. Review.
Outcomes after curative treatment for cryptogenic cirrhosis-associated hepatocellular carcinoma satisfying the Milan criteria.
Takuma Y, Nouso K, Makino Y, Gotoh T, Toshikuni N, Morimoto Y, Shimomura H, Yamamoto H.
J Gastroenterol Hepatol. 2011 Sep;26(9):1417-24. doi: 10.1111/j.1440-1746.2011.06775.x.
No more pilots, a phase III trial of fibrates in primary biliary cirrhosis is long overdue!
Halliday JS, Chapman RW.
J Gastroenterol Hepatol. 2011 Sep;26(9):1345-6. doi: 10.1111/j.1440-1746.2011.06837.x. No abstract available.
In this issue.
Chitturi S, Pavli P.
J Gastroenterol Hepatol. 2011 Sep;26(9):v. doi: 10.1111/j.1440-1746.2010.info272.x. No abstract available.
Non-invasive estimation of liver fibrosis in non-alcoholic fatty liver disease using the 13 C-caffeine breath test.
Park GJ, Wiseman E, George J, Katelaris PH, Seow F, Fung C, Ngu MC.
J Gastroenterol Hepatol. 2011 Sep;26(9):1411-6. doi: 10.1111/j.1440-1746.2011.06760.x.
Respiratory effects of balloon occluded retrograde transvenous obliteration of gastric varices: a prospective controlled study.
Arai H, Abe T, Takayama H, Toyoda M, Mori K, Ueno T, Takagi H, Shimoda R.
J Gastroenterol Hepatol. 2011 Sep;26(9):1389-94. doi: 10.1111/j.1440-1746.2011.06727.x.
Is transient elastography valuable for high-risk esophageal varices prediction in patients with hepatitis-B-related cirrhosis?
Chen YP, Zhang Q, Dai L, Liang XE, Peng J, Hou JL.
J Gastroenterol Hepatol. 2012 Mar;27(3):533-9. doi: 10.1111/j.1440-1746.2011.06889.x.
Laparoscopic splenectomy with interferon therapy in 100 hepatitis-C-virus-cirrhotic patients with hypersplenism and thrombocytopenia.
Akahoshi T, Tomikawa M, Kawanaka H, Furusyo N, Kinjo N, Tsutsumi N, Nagao Y, Hayashi J, Hashizume M, Maehara Y.
J Gastroenterol Hepatol. 2012 Feb;27(2):286-90. doi: 10.1111/j.1440-1746.2011.06870.x.
Lactulose a day keeps encephalopathy at bay.
Klinken E, MacQuillan G.
J Gastroenterol Hepatol. 2011 Jun;26(6):939-40. doi: 10.1111/j.1440-1746.2011.06742.x. No abstract available.
Non-invasive assessment of liver fibrosis: the gap between ideal and real.
Kim SU, Han KH, Ahn SH.
J Gastroenterol Hepatol. 2011 Jun;26(6):937-9. doi: 10.1111/j.1440-1746.2011.06741.x. No abstract available.
Focal nodular hyperplasia or focal nodular hyperplasia-like lesions of the liver: a special emphasis on diagnosis.
Choi JY, Lee HC, Yim JH, Shim JH, Lim YS, Shin YM, Yu ES, Suh DJ.
J Gastroenterol Hepatol. 2011 Jun;26(6):1004-9. doi: 10.1111/j.1440-1746.2011.06659.x.
Application of the HALF index obviates the need for liver biopsy in half of all patients with chronic hepatitis B.
Lee HJ, Seo YS, Kim DJ, Kang HS, An H, Kim JH, Cheong JY, Yim HJ, Yeon JE, Lee HS, Byun KS, Cho SW, Kim DJ, Um SH, Kim CD, Ryu HS.
J Gastroenterol Hepatol. 2011 Jun;26(6):987-95. doi: 10.1111/j.1440-1746.2010.06609.x.
Biomarkers of liver fibrosis.
Adams LA.
J Gastroenterol Hepatol. 2011 May;26(5):802-9. doi: 10.1111/j.1440-1746.2010.06612.x. Review.
Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapy.
El Awady MK, Anany MA, Esmat G, Zayed N, Tabll AA, Helmy A, El Zayady AR, Abdalla MS, Sharada HM, El Raziky M, El Akel W, Abdalla S, Bader El Din NG.
J Gastroenterol Hepatol. 2011 May;26(5):843-50. doi: 10.1111/j.1440-1746.2010.06605.x.
Diagnostic sensitivity of hepatocellular carcinoma imaging and its application to non-cirrhotic patients.
Lin MT, Chen CL, Wang CC, Cheng YF, Eng HL, Wang JH, Chiu KW, Lee CM, Hu TH.
J Gastroenterol Hepatol. 2011 Apr;26(4):745-50. doi: 10.1111/j.1440-1746.2010.06501.x.
Education and imaging. Hepatobiliary and pancreatic: Pseudocirrhosis after chemotherapy.
Liu CH, Chao TY.
J Gastroenterol Hepatol. 2011 Apr;26(4):788. doi: 10.1111/j.1440-1746.2011.06712.x. No abstract available.
Ubiquitin-proteasome profiling for enhanced detection of hepatocellular carcinoma in patients with chronic liver disease.
Qu KZ, Zhang K, Ma W, Li H, Wang X, Zhang X, Giles F, Lai M, Afdhal NH, Albitar M.
J Gastroenterol Hepatol. 2011 Apr;26(4):751-8. doi: 10.1111/j.1440-1746.2010.06491.x.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on